You can buy or sell BLCM and other stocks, options, ETFs, and crypto commission-free!
Bellicum Pharmaceuticals, Inc. Common Stock, also called Bellicum Pharmaceuticals, is a clinical stage biopharmaceutical company. Read More It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.
52 Week High
52 Week Low
— per share
Expected May 5, After Hours